Harada S, Takamoto M, Harada Y, Ninomiya H, Maruyama M, Ishibashi T, Shinoda A
Kekkaku. 1989 Aug;64(8):529-36.
We studied tuberculin reactivity and clinical course after starting chemotherapy in patients with active pulmonary tuberculosis divided by four age-groups less than 29, 30-49, 50-69 and 70 years and more. The skin test to tuberculin purified protein derivative (PPD) was examined in 178 cases of active pulmonary tuberculosis, 120 cases of lung cancer, 25 cases of atypical mycobacteriosis and 466 cases of the other respiratory diseases. The average size of tuberculin reaction in pulmonary tuberculosis decreased with age, but significantly higher than that in patients with other nontuberculous pulmonary diseases of the same age-group. The size of PPD skin test in the group of 70 years and more was significantly lower than other age-groups in pulmonary tuberculosis. We compared the time required for negative conversion of sputum by culture after primary chemotherapy among the different age-groups in pulmonary tuberculosis. It revealed that the time for negative conversion tended to be longer with age, and the time in the group 70 years and more was significantly longer than that of the group less than 29 years of age, although no significant differences in the radiographic severity and conditions of chemotherapy were observed. Finally, the PPD-induced lymphocyte proliferation test in vitro was done in newly diagnosed patients with pulmonary tuberculosis. The patients were divided into two groups by the size of PPD skin test (high responder more than 16 mm and low responder less than 15 mm of erythema induced by PPD).(ABSTRACT TRUNCATED AT 250 WORDS)
我们研究了活动性肺结核患者按年龄分为小于29岁、30 - 49岁、50 - 69岁和70岁及以上四个年龄组开始化疗后的结核菌素反应性和临床病程。对178例活动性肺结核患者、120例肺癌患者、25例非典型分枝杆菌病患者和466例其他呼吸道疾病患者进行了结核菌素纯蛋白衍生物(PPD)皮肤试验。肺结核患者结核菌素反应的平均大小随年龄下降,但明显高于同年龄组其他非结核性肺部疾病患者。70岁及以上组肺结核患者的PPD皮肤试验大小明显低于其他年龄组。我们比较了肺结核不同年龄组初次化疗后痰培养转阴所需时间。结果显示,转阴时间随年龄增长而趋于延长,70岁及以上组的时间明显长于小于29岁组,尽管在影像学严重程度和化疗条件方面未观察到显著差异。最后,对新诊断的肺结核患者进行了PPD诱导的体外淋巴细胞增殖试验。根据PPD皮肤试验大小(PPD诱导红斑大于16 mm为高反应者,小于15 mm为低反应者)将患者分为两组。